Neuroscience

The study of the nervous system's molecular, cellular, developmental, and functional aspects comprises neuroscience research, and is key to understanding the many facets of human sleep, pain, and addiction.

Researchers in SRI’s Center for Health Sciences Neuroscience Program conduct extensive research using biochemistry, molecular biology, proteomics, electrophysiology, and behavioral testing techniques. They also study the brain's structure and function using magnetic resonance imaging technology.

SRI's Center for Neuroscience and Metabolic Diseases combines world-class basic science with contract research to provide an environment ideal to partner with clients and help advance research and development programs. We conduct basic research in sleep, circadian rhythms, pain, and addiction using techniques in biochemistry, molecular biology, proteomics, electrophysiology, and behavioral testing.

Projects

scientist working at a computer

SRI is investigating novel methods and treatments to improve cognitive deficits caused by diseases such as Alzheimer’s and depression.

nicotinic receptors affect brain activity

To support more effective cessation treatments, SRI researchers are exploring how nicotinic receptors affect brain activity in response to smoking.

diagram of nicotinic receptors

SRI is investigating whether the nicotine in tobacco smoke may be useful in meeting the urgent need to manage Parkinson’s disease.

cigarette being snapped in half

SRI is analyzing the genetics of smoking and related characteristics, using data from a large-scale National Cancer Institute study on smoking cessation.

twin boys

SRI established the Twin Research Registry as part of its scientific research and efforts to discover more about human behavior. Fraternal and identical twins and multiples of all ages are invited to join the Registry for consideration for research studies.

Press Releases

Gary Swang, director of SRI International's Center for Health Sciences

Gary E. Swan, Ph.D., director of SRI International's Center for Health Sciences, has been elected by the membership of the Society for Research on Nicotine and Tobacco (SRNT) as its president-elect and will serve as president in 2012.

image of a mouse brain

Researchers from SRI’s Center for Neuroscience and Metabolic Diseases will use Inscopix’s nVista HD imaging system to gain a better understanding of normal brain function and the dysfunctions of neural circuitry that underlie neurological and neuropsychiatric disorders.

Joseph Rogers

In his career, Rogers has focused on age-related neurologic diseases. He is best known for showing that inflammatory responses occur in almost all major age-related brain disorders and cause substantial damage, with his seminal paper in the area receiving nearly 1,200 citations to date.

Adolf Pfefferbaum

The Research Society on Alcoholism (RSA) awarded its 2011 Distinguished Researcher Award to Adolf Pfefferbaum, M.D., director of the Neuroscience Program in the Center for Health Sciences at SRI International and a professor at Stanford University School of Medicine.

SRI International, an independent nonprofit research and development organization, announced today that its Center for Neuroscience has entered into a research collaboration with F. Hoffmann-La Roche.

Topics: Neuroscience

SRI International was awarded a $9.5 million contract by the National Institute of Neurological Disorders and Stroke (NINDS) to develop medical countermeasures to prevent, diagnose, and treat conditions caused by potential and existing chemical agents of terrorism.

Topics: Neuroscience

A luncheon seminar will focus on SRI International’s work in cancer research, immunology and inflammation, infectious disease, and neuroscience.

SRI International, an independent nonprofit research and development institute, announced today that a new Neurodegenerative Diseases Research Program has been established within its Center for Health Sciences.

SRI International, an independent nonprofit research and development institute, announced today that Thomas S. Kilduff, Ph.D., director of SRI International's Center for Neuroscience, has been named a Fellow of the American Association for the Advancement of Science (AAAS).